[Federal Register Volume 85, Number 67 (Tuesday, April 7, 2020)]
[Notices]
[Page 19504]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-07277]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-619]
Bulk Manufacturer of Controlled Substances Application: American
Radiolabeled Chem
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may file written comments on or objections to
the issuance of the proposed registration on or before June 8, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on March 7, 2020, American Radiolabeled Chem, 101 Arc
Drive, Saint Louis, Missouri 63146, applied to be registered as a bulk
manufacturer of the following basic class(es) of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid............. 2010 I
Ibogaine.............................. 7260 I
Lysergic acid diethylamide............ 7315 I
Tetrahydrocannabinols................. 7370 I
Dimethyltryptamine.................... 7435 I
1-[1-(2-Thienyl)cyclohexyl]piperidine. 7470 I
Dihydromorphine....................... 9145 I
Heroin................................ 9200 I
Normorphine........................... 9313 I
Amphetamine........................... 1100 II
Methamphetamine....................... 1105 II
Amobarbital........................... 2125 II
Phencyclidine......................... 7471 II
Phenylacetone......................... 8501 II
Cocaine............................... 9041 II
Codeine............................... 9050 II
Dihydrocodeine........................ 9120 II
Oxycodone............................. 9143 II
Hydromorphone......................... 9150 II
Ecgonine.............................. 9180 II
Hydrocodone........................... 9193 II
Meperidine............................ 9230 II
Metazocine............................ 9240 II
Methadone............................. 9250 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms).
Morphine.............................. 9300 II
Oripavine............................. 9330 II
Thebaine.............................. 9333 II
Oxymorphone........................... 9652 II
Phenazocine........................... 9715 II
Carfentanil........................... 9743 II
Fentanyl.............................. 9801 II
------------------------------------------------------------------------
The company plans to manufacture small quantities of the above-
listed controlled substances as radiolabeled compounds for biochemical
research. No other activities for these drug codes are authorized for
this registration.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-07277 Filed 4-6-20; 8:45 am]
BILLING CODE 4410-09-P